Wakefit Innovations will list on December 15, with the grey market premium (GMP) slipping sharply in recent days—now hovering in the low single digits. After a muted subscription, analysts read the GMP as signaling a flat-to-marginal listing versus the ₹185–₹195 price band, amid broader market volatility and cautious sentiment.
Wakefit Innovations, a D2C home and sleep solutions brand, saw overall subscription around 2.52x, with allotment finalized on December 11 and shares credited ahead of listing. GMP trends have fallen from early highs to ₹3–₹7 across trackers, indicating limited listing pop. The IPO size was about ₹1,288.89 crore, with a lot size of 76 shares; market watchers advise focusing on fundamentals over short-term GMP swings.
Notable updates
• Listing date: December 15 on NSE and BSE
• Subscription: ~2.52x overall; bids ~91.67 million vs 36.35 million on offer
• GMP trend: dropped >90% from early peak; recent prints ~₹3–₹7, implying flat debut risk
• Price band: ₹185–₹195; lot size: 76 shares
• Context: Volatile markets and cautious risk appetite weighing on near-term IPO performance
Major takeaway
A sharply lower GMP suggests a subdued debut; near-term returns may be limited. Longer-term prospects hinge on execution, margins, and D2C growth versus intensifying competition.
Sources: NDTV Profit, Business Standard, LiveMint, IPO Watch, Times Now